Global Pharmaceuticals & Biotech Most Popular Stocks

Isodiol International

Market Cap: US$128.0

Engages in the development, marketing, distribution, and sale of hemp-based consumer packaged goods and solutions in Canada and the United States.

Lattice Biologics

Market Cap: US$128.0

A biotech company, develops, manufactures, and markets biologics products for use in the field of bone regeneration in dental, spine, and general orthopedic indications worldwide.

Emerging World Pharma

Market Cap: US$119.0

Invests in generic based pharmaceutical companies manufacturing within developing nations.

HEALTHeUNIVERSE

Market Cap: US$117.0

Healtheuniverse, Inc., a biotechnology development company, engages in the research, development, and commercialization of biopharmaceutical, biomedical, nutraceutical, and cosmeceutical products.

RxElite

Market Cap: US$116.0

Engages in the development, manufacture, and marketing of generic prescription drug products in specialty generic markets.

VMS Rehab Systems

Market Cap: US$111.0

Engages in generic drug and home healthcare businesses.

RVL Pharmaceuticals

Market Cap: US$111.0

Operates as a specialty pharmaceutical company.

RenovaCare

Market Cap: US$87.0

A development-stage biotech and medical device company, focuses on the research, development, and commercialization of autologous cellular therapies for use in medical and aesthetic applications.

Alliance Growers

Market Cap: US$85.0

Engages in acquiring investments in and developing projects in the medical cannabis sector in British Columbia.

Gnomestar Craft

Market Cap: US$85.0

Engages in the production and distribution of cannabis product for medical and recreational use in Canada.

Cardax

Market Cap: US$82.0

A biopharmaceutical company, develops and commercializes dietary supplements for inflammatory health and pharmaceuticals for chronic diseases driven by inflammation and oxidative stress.

Yield10 Bioscience

Market Cap: US$73.0

Operates as an agricultural bioscience company that focuses on commercializing products using the Camelina oilseeds in the United States.

Indigenous Bloom Hemp

Market Cap: US$71.0

Focuses on the production of hemp products.

Interpharm Holdings

Market Cap: US$66.0

Develops, manufactures, and markets generic prescription strength and over-the-counter pharmaceuticals.

North Bud Farms

Market Cap: US$66.0

Through its subsidiaries, focuses on the production of pharmaceutical-grade cannabis and food grade cannabinoid infused inputs for the pharmaceutical and recreational cannabis markets in Canada.

Capha Pharmaceuticals

Market Cap: US$64.0

Does not have significant operations.

MJ Holdings

Market Cap: US$58.0

A cannabis holding company, engages in cultivation management, asset, and infrastructure development business in Nevada.

Panacos Pharmaceuticals

Market Cap: US$53.0

A development stage biotechnology company, engages in the discovery and development of small-molecule oral drugs designed to treat human immunodeficiency virus (HIV) and other human viral diseases.

Inyx

Market Cap: US$53.0

Through its wholly-owned subsidiaries, operates as a specialty pharmaceutical company in the United States, Canada, and Europe.

Baudax Bio

Market Cap: US$52.0

A pharmaceutical company, develops and commercializes products for hospital and other acute care related settings.

Arno Therapeutics

Market Cap: US$49.0

A biopharmaceutical company, develops products for the treatment of cancer and other life threatening diseases.

Mymetics

Market Cap: US$45.0

Engages in the research and development of vaccines for infectious and life disabling diseases in Switzerland.

Callitas Health

Market Cap: US$45.0

Provides over the counter consumer health and wellness products in the United States and Canada.

Antigenics

Market Cap: US$45.0

A clinical-stage biopharmaceutical company, discovers, manufactures, and develops immunotherapies for cancer.

Ember Therapeutics

Market Cap: US$43.0

Operates as a clinical stage biopharmaceutical company.

Integrative Health Technologies

Market Cap: US$40.0

Provides fee-based clinical trials, research and development, and consulting and testing services to the healthcare and nutritional industries.

Response Genetics

Market Cap: US$38.0

A life sciences company, researches, develops, markets, and sells pharmacogenomic tests for use in the treatment of cancer in the United States, Europe, and internationally.

Canntab Therapeutics

Market Cap: US$38.0

A phytopharmaceutical company, engages in the research and development of advanced pharmaceutical grade formulations of cannabinoids in Canada.

Claritas Pharmaceuticals

Market Cap: US$37.0

A clinical-stage specialty pharmaceutical company, focuses on developing and commercializing therapies for patients with unmet medical needs.

Goodbody Health

Market Cap: US$36.0

Goodbody Health Inc., a wellness company, provides health and wellness range of products and services in the United Kingdom.

ARYx Therapeutics

Market Cap: US$33.0

ARYx Therapeutics, Inc. discovers and develops novel therapies for large, chronic, and oral markets.

Deltagen

Market Cap: US$32.0

Provides drug discovery tools and services to the biopharmaceutical industry.

Targeted Medical Pharma

Market Cap: US$29.0

A specialty pharmaceutical company, doing business as Physician Therapeutics, develops and commercializes amino acid based medications to physicians, pharmacies, and patients in the United States.

Genvor

Market Cap: US$29.0

Develops plant-based defense technology designed to help farmers achieve global food security.

FluoroPharma Medical

Market Cap: US$27.0

A biopharmaceutical company, engages in the discovery, development, and commercialization of molecular imaging pharmaceuticals with initial applications in the area of cardiology in the United States.

Anthera Pharmaceuticals

Market Cap: US$26.0

A biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs.